Abstract
Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) were first introduced for the treatment of type 2 diabetes (T2D) in 2005. Despite the hig......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
